This article by Lorena O’Neil was published in Louisiana Illuminator on Oct. 31, 2024
Health care workers and advocates filed a lawsuit Thursday against the state of Louisiana, on their own and on behalf of their patients, challenging Act 246, a new state law reclassifying mifepristone and misoprostol as controlled dangerous substances.